Identification of PB2 Mutations Responsible for the Efficient Replication of H5N1 Influenza Viruses in Human Lung Epithelial Cells

Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses...

Full description

Saved in:
Bibliographic Details
Published inJournal of virology Vol. 89; no. 7; pp. 3947 - 3956
Main Authors Yamaji, Reina, Yamada, Shinya, Le, Mai Q., Li, Chengjun, Chen, Hualan, Qurnianingsih, Ema, Nidom, Chairul A., Ito, Mutsumi, Sakai-Tagawa, Yuko, Kawaoka, Yoshihiro
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.04.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance. IMPORTANCE Highly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2.
AbstractList Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance.UNLABELLEDHighly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance.Highly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2.IMPORTANCEHighly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2.
Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance. IMPORTANCE Highly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2.
Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance. IMPORTANCE Highly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2.
Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance. Highly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2.
Author Le, Mai Q.
Nidom, Chairul A.
Kawaoka, Yoshihiro
Sakai-Tagawa, Yuko
Yamaji, Reina
Qurnianingsih, Ema
Chen, Hualan
Ito, Mutsumi
Yamada, Shinya
Li, Chengjun
Author_xml – sequence: 1
  givenname: Reina
  surname: Yamaji
  fullname: Yamaji, Reina
  organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
– sequence: 2
  givenname: Shinya
  surname: Yamada
  fullname: Yamada, Shinya
  organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
– sequence: 3
  givenname: Mai Q.
  surname: Le
  fullname: Le, Mai Q.
  organization: National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
– sequence: 4
  givenname: Chengjun
  surname: Li
  fullname: Li, Chengjun
  organization: State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China
– sequence: 5
  givenname: Hualan
  surname: Chen
  fullname: Chen, Hualan
  organization: State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China
– sequence: 6
  givenname: Ema
  surname: Qurnianingsih
  fullname: Qurnianingsih, Ema
  organization: Avian Influenza Research Center, Airlangga University, Surabaya, Indonesia
– sequence: 7
  givenname: Chairul A.
  surname: Nidom
  fullname: Nidom, Chairul A.
  organization: Avian Influenza Research Center, Airlangga University, Surabaya, Indonesia
– sequence: 8
  givenname: Mutsumi
  surname: Ito
  fullname: Ito, Mutsumi
  organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
– sequence: 9
  givenname: Yuko
  surname: Sakai-Tagawa
  fullname: Sakai-Tagawa, Yuko
  organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
– sequence: 10
  givenname: Yoshihiro
  surname: Kawaoka
  fullname: Kawaoka, Yoshihiro
  organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Wisconsin, USA, Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25609813$$D View this record in MEDLINE/PubMed
BookMark eNqNks1v1DAQxS1URLeFG2fkIwdSPP5I7AsSXS3souVDCCpuluPYrZHXCXGC1B75yzHdFhXEgdPImt97euOZI3SQ-uQQegzkBIDK52_ONieEMSor4PfQAoiSlRDAD9CCEEorweSXQ3SU81dCgPOaP0CHVNQFA7ZAPzadS1PwwZop9An3Hn84pfjtPF2_M_7o8lBqaKPDvh_xdOHwyhc-FF3pDvGOdC3eAd4kH2eXrgw-C-OcXcYh4fW8Mwlv53SOV0MoJjGYiJcuxvwQ3fcmZvfoph6jz69Wn5bravv-9Wb5cltZLtlUuZp2QhAQkihHvGiUEg2pbWMUSCNV7Rva8g6ctDUAF7ZlwvhWgeg4p6DYMXqx9x3mduc6W_KPJuphDDszXureBP1nJ4ULfd5_15yX_1W0GDy9MRj7b7PLk96FbMsIJrl-zhrqpmaCgmT_gda0sILIgj65G-t3ntsdFYDuATv2OY_Oaxv22ykpQ9RA9K9D0OUQ9PUhaOBF9Owv0a3vP_GfXR6z0w
CitedBy_id crossref_primary_10_1038_srep24154
crossref_primary_10_3390_v14112454
crossref_primary_10_3390_v16030357
crossref_primary_10_1128_JVI_01722_20
crossref_primary_10_1007_s00705_016_3137_8
crossref_primary_10_1038_s41426_018_0072_7
crossref_primary_10_1128_JVI_01930_19
crossref_primary_10_1080_13102818_2018_1541760
crossref_primary_10_1055_s_0044_1788039
crossref_primary_10_1111_tbed_13294
crossref_primary_10_1371_journal_pone_0226108
crossref_primary_10_3390_pathogens12010036
crossref_primary_10_1038_s41594_023_01043_2
crossref_primary_10_3390_vaccines9010026
crossref_primary_10_1007_s00705_016_2826_7
crossref_primary_10_3390_vaccines11111628
crossref_primary_10_1186_s12864_019_5820_0
crossref_primary_10_1016_j_virol_2015_03_009
crossref_primary_10_1038_s41541_021_00395_4
crossref_primary_10_1016_j_onehlt_2015_03_001
crossref_primary_10_3390_ijms25158550
crossref_primary_10_1038_s41426_018_0050_0
crossref_primary_10_1038_srep43691
crossref_primary_10_3390_v13122357
crossref_primary_10_1111_tbed_13601
crossref_primary_10_3389_fmicb_2019_01271
crossref_primary_10_1371_journal_pone_0312134
crossref_primary_10_3390_v14030643
Cites_doi 10.1099/vir.0.018143-0
10.1038/nature07720
10.1038/nature07745
10.1371/journal.ppat.1000252
10.1038/ncomms6021
10.1093/oxfordjournals.aje.a118408
10.1371/journal.pone.0001190
10.1074/jbc.M111.262048
10.1128/JVI.06203-11
10.1056/NEJMra052211
10.1371/journal.ppat.0030133
10.1038/440435a
10.1099/vir.0.036434-0
10.1056/NEJMoa044021
10.1073/pnas.96.16.9345
10.1046/j.1365-2443.1999.00275.x
10.1128/AAC.38.12.2827
10.1006/viro.1994.1615
10.1056/NEJMra0707279
10.1126/science.279.5349.393
10.1016/0042-6822(83)90150-2
10.1371/journal.ppat.1003279
10.1128/JVI.79.18.12058-12064.2005
10.1128/JVI.00760-13
10.1038/nature03974
10.1371/journal.ppat.1001034
10.1371/journal.pone.0021740
10.1038/nature14008
10.1186/1471-2105-9-S1-S18
10.1038/nsmb.1421
10.1074/jbc.M112.392878
10.1006/viro.1999.9820
10.1128/JVI.01698-07
10.1186/1743-422X-10-243
10.1128/JVI.01694-10
10.1128/JVI.00980-13
10.1016/S0140-6736(08)60493-6
10.1371/journal.pone.0009025
10.1128/JVI.01373-09
10.1099/vir.0.80755-0
10.1126/science.1124513
10.1038/nsmb1212
10.1074/jbc.M300130200
10.1038/ncomms1804
10.1128/JVI.02677-05
10.1128/JVI.02642-09
ContentType Journal Article
Copyright Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology
Copyright_xml – notice: Copyright © 2015, American Society for Microbiology. All Rights Reserved.
– notice: Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T2
7U1
7U9
C1K
H94
5PM
DOI 10.1128/JVI.03328-14
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Health and Safety Science Abstracts (Full archive)
Risk Abstracts
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Risk Abstracts
AIDS and Cancer Research Abstracts
Health & Safety Science Abstracts
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE - Academic

Risk Abstracts
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Adaptive Mutations of H5N1 Virus
EISSN 1098-5514
EndPage 3956
ExternalDocumentID PMC4403392
25609813
10_1128_JVI_03328_14
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations ISEW, Vietnam
GeographicLocations_xml – name: ISEW, Vietnam
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
29L
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
6TJ
85S
AAFWJ
AAGFI
AAYJJ
AAYXX
ABPPZ
ACGFO
ACNCT
ADBBV
ADXHL
AENEX
AFFNX
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CITATION
CS3
D0S
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
MVM
N9A
O9-
OHT
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UPT
VH1
W2D
W8F
WH7
WOQ
X7M
Y6R
YQT
ZGI
ZXP
~02
~KM
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T2
7U1
7U9
C1K
H94
5PM
ID FETCH-LOGICAL-c483t-e62d55015809e0f57995706c7a918a896f72b4d1e8c61145cb35afb915d442193
ISSN 0022-538X
1098-5514
IngestDate Thu Aug 21 14:00:26 EDT 2025
Sun Aug 24 04:13:21 EDT 2025
Thu Jul 10 19:14:24 EDT 2025
Mon Jul 21 06:02:08 EDT 2025
Tue Jul 01 01:02:36 EDT 2025
Thu Apr 24 23:06:34 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License Copyright © 2015, American Society for Microbiology. All Rights Reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c483t-e62d55015809e0f57995706c7a918a896f72b4d1e8c61145cb35afb915d442193
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Citation Yamaji R, Yamada S, Le MQ, Li C, Chen H, Qurnianingsih E, Nidom CA, Ito M, Sakai-Tagawa Y, Kawaoka Y. 2015. Identification of PB2 mutations responsible for the efficient replication of H5N1 influenza viruses in human lung epithelial cells. J Virol 89:3947–3956. doi:10.1128/JVI.03328-14.
OpenAccessLink https://jvi.asm.org/content/jvi/89/7/3947.full.pdf
PMID 25609813
PQID 1662635508
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4403392
proquest_miscellaneous_1676352183
proquest_miscellaneous_1662635508
pubmed_primary_25609813
crossref_citationtrail_10_1128_JVI_03328_14
crossref_primary_10_1128_JVI_03328_14
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-04-01
PublicationDateYYYYMMDD 2015-04-01
PublicationDate_xml – month: 04
  year: 2015
  text: 2015-04-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of virology
PublicationTitleAlternate J Virol
PublicationYear 2015
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_48_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_46_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
Kurihara T (e_1_3_2_47_2) 2009; 35
19194458 - Nature. 2009 Apr 16;458(7240):909-13
18454157 - Nat Struct Mol Biol. 2008 May;15(5):500-6
18315849 - BMC Bioinformatics. 2008;9 Suppl 1:S18
20700447 - PLoS Pathog. 2010;6(8):e1001034
25409142 - Nature. 2014 Dec 18;516(7531):355-60
6868370 - Virology. 1983 Jun;127(2):361-73
22549831 - Nat Commun. 2012;3:802
9430591 - Science. 1998 Jan 16;279(5349):393-6
16192482 - N Engl J Med. 2005 Sep 29;353(13):1374-85
10430945 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50
21738783 - PLoS One. 2011;6(6):e21740
10484749 - Virology. 1999 Aug 15;261(1):15-9
25289523 - Nat Commun. 2014;5:5021
18199865 - N Engl J Med. 2008 Jan 17;358(3):261-73
20016035 - J Gen Virol. 2010 May;91(Pt 5):1284-9
22090209 - J Gen Virol. 2012 Mar;93(Pt 3):531-40
23616660 - J Virol. 2013 Jul;87(13):7200-9
17922570 - PLoS Pathog. 2007 Oct 5;3(10):1374-9
19793828 - J Virol. 2009 Dec;83(23):12325-35
10526235 - Genes Cells. 1999 Aug;4(8):475-85
18030326 - PLoS One. 2007;2(11):e1190
20140252 - PLoS One. 2010;5(2):e9025
20181719 - J Virol. 2010 May;84(9):4395-406
7975212 - Virology. 1994 Nov 15;205(1):17-23
12646557 - J Biol Chem. 2003 May 30;278(22):20381-8
16140781 - J Virol. 2005 Sep;79(18):12058-64
23886034 - Virol J. 2013;10:243
23436652 - J Biol Chem. 2013 Apr 19;288(16):11013-23
7695269 - Antimicrob Agents Chemother. 1994 Dec;38(12):2827-37
23555271 - PLoS Pathog. 2013 Mar;9(3):e1003279
15831934 - J Gen Virol. 2005 May;86(Pt 5):1239-49
16543414 - Science. 2006 Apr 21;312(5772):404-10
22090127 - J Virol. 2012 Feb;86(3):1750-7
16840327 - J Virol. 2006 Aug;80(15):7469-80
16554799 - Nature. 2006 Mar 23;440(7083):435-6
17310249 - Nat Struct Mol Biol. 2007 Mar;14(3):229-33
18400288 - Lancet. 2008 Apr 26;371(9622):1427-34
23926340 - J Virol. 2013 Oct;87(20):11063-75
19194459 - Nature. 2009 Apr 16;458(7240):914-8
20962098 - J Virol. 2011 Jan;85(1):357-65
19119420 - PLoS Pathog. 2009 Jan;5(1):e1000252
21816827 - J Biol Chem. 2011 Oct 7;286(40):34504-13
15668219 - N Engl J Med. 2005 Jan 27;352(4):333-40
18032512 - J Virol. 2008 Feb;82(3):1146-54
16007072 - Nature. 2005 Jul 14;436(7048):191-2
References_xml – ident: e_1_3_2_20_2
  doi: 10.1099/vir.0.018143-0
– ident: e_1_3_2_40_2
  doi: 10.1038/nature07720
– ident: e_1_3_2_39_2
  doi: 10.1038/nature07745
– ident: e_1_3_2_10_2
  doi: 10.1371/journal.ppat.1000252
– ident: e_1_3_2_29_2
  doi: 10.1038/ncomms6021
– ident: e_1_3_2_48_2
  doi: 10.1093/oxfordjournals.aje.a118408
– ident: e_1_3_2_30_2
  doi: 10.1371/journal.pone.0001190
– ident: e_1_3_2_9_2
  doi: 10.1074/jbc.M111.262048
– ident: e_1_3_2_24_2
  doi: 10.1128/JVI.06203-11
– ident: e_1_3_2_5_2
  doi: 10.1056/NEJMra052211
– ident: e_1_3_2_11_2
  doi: 10.1371/journal.ppat.0030133
– ident: e_1_3_2_19_2
  doi: 10.1038/440435a
– ident: e_1_3_2_22_2
  doi: 10.1099/vir.0.036434-0
– ident: e_1_3_2_8_2
  doi: 10.1056/NEJMoa044021
– ident: e_1_3_2_33_2
  doi: 10.1073/pnas.96.16.9345
– ident: e_1_3_2_37_2
  doi: 10.1046/j.1365-2443.1999.00275.x
– ident: e_1_3_2_41_2
  doi: 10.1128/AAC.38.12.2827
– ident: e_1_3_2_44_2
  doi: 10.1006/viro.1994.1615
– ident: e_1_3_2_6_2
  doi: 10.1056/NEJMra0707279
– ident: e_1_3_2_2_2
  doi: 10.1126/science.279.5349.393
– ident: e_1_3_2_43_2
  doi: 10.1016/0042-6822(83)90150-2
– ident: e_1_3_2_25_2
  doi: 10.1371/journal.ppat.1003279
– ident: e_1_3_2_14_2
  doi: 10.1128/JVI.79.18.12058-12064.2005
– ident: e_1_3_2_17_2
  doi: 10.1128/JVI.00760-13
– ident: e_1_3_2_4_2
  doi: 10.1038/nature03974
– ident: e_1_3_2_12_2
  doi: 10.1371/journal.ppat.1001034
– ident: e_1_3_2_26_2
  doi: 10.1371/journal.pone.0021740
– ident: e_1_3_2_34_2
  doi: 10.1038/nature14008
– ident: e_1_3_2_31_2
  doi: 10.1186/1471-2105-9-S1-S18
– ident: e_1_3_2_38_2
  doi: 10.1038/nsmb.1421
– ident: e_1_3_2_42_2
  doi: 10.1074/jbc.M112.392878
– ident: e_1_3_2_3_2
  doi: 10.1006/viro.1999.9820
– ident: e_1_3_2_28_2
  doi: 10.1128/JVI.01698-07
– ident: e_1_3_2_18_2
  doi: 10.1186/1743-422X-10-243
– ident: e_1_3_2_16_2
  doi: 10.1128/JVI.01694-10
– ident: e_1_3_2_27_2
  doi: 10.1128/JVI.00980-13
– ident: e_1_3_2_7_2
  doi: 10.1016/S0140-6736(08)60493-6
– ident: e_1_3_2_32_2
  doi: 10.1371/journal.pone.0009025
– volume: 35
  start-page: 307
  year: 2009
  ident: e_1_3_2_47_2
  article-title: A barrier function made up of the receptor preference of the virus and the paucity of receptors in human airways against avian influenza virus infection
  publication-title: Kawasaki Med J
– ident: e_1_3_2_23_2
  doi: 10.1128/JVI.01373-09
– ident: e_1_3_2_35_2
  doi: 10.1099/vir.0.80755-0
– ident: e_1_3_2_46_2
  doi: 10.1126/science.1124513
– ident: e_1_3_2_13_2
  doi: 10.1038/nsmb1212
– ident: e_1_3_2_36_2
  doi: 10.1074/jbc.M300130200
– ident: e_1_3_2_21_2
  doi: 10.1038/ncomms1804
– ident: e_1_3_2_45_2
  doi: 10.1128/JVI.02677-05
– ident: e_1_3_2_15_2
  doi: 10.1128/JVI.02642-09
– reference: 16543414 - Science. 2006 Apr 21;312(5772):404-10
– reference: 18032512 - J Virol. 2008 Feb;82(3):1146-54
– reference: 20181719 - J Virol. 2010 May;84(9):4395-406
– reference: 25289523 - Nat Commun. 2014;5:5021
– reference: 18199865 - N Engl J Med. 2008 Jan 17;358(3):261-73
– reference: 20962098 - J Virol. 2011 Jan;85(1):357-65
– reference: 10430945 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50
– reference: 25409142 - Nature. 2014 Dec 18;516(7531):355-60
– reference: 15668219 - N Engl J Med. 2005 Jan 27;352(4):333-40
– reference: 18030326 - PLoS One. 2007;2(11):e1190
– reference: 22090127 - J Virol. 2012 Feb;86(3):1750-7
– reference: 23436652 - J Biol Chem. 2013 Apr 19;288(16):11013-23
– reference: 23555271 - PLoS Pathog. 2013 Mar;9(3):e1003279
– reference: 16140781 - J Virol. 2005 Sep;79(18):12058-64
– reference: 21738783 - PLoS One. 2011;6(6):e21740
– reference: 18454157 - Nat Struct Mol Biol. 2008 May;15(5):500-6
– reference: 20140252 - PLoS One. 2010;5(2):e9025
– reference: 7695269 - Antimicrob Agents Chemother. 1994 Dec;38(12):2827-37
– reference: 10526235 - Genes Cells. 1999 Aug;4(8):475-85
– reference: 15831934 - J Gen Virol. 2005 May;86(Pt 5):1239-49
– reference: 19194458 - Nature. 2009 Apr 16;458(7240):909-13
– reference: 23886034 - Virol J. 2013;10:243
– reference: 17310249 - Nat Struct Mol Biol. 2007 Mar;14(3):229-33
– reference: 17922570 - PLoS Pathog. 2007 Oct 5;3(10):1374-9
– reference: 22090209 - J Gen Virol. 2012 Mar;93(Pt 3):531-40
– reference: 9430591 - Science. 1998 Jan 16;279(5349):393-6
– reference: 7975212 - Virology. 1994 Nov 15;205(1):17-23
– reference: 16007072 - Nature. 2005 Jul 14;436(7048):191-2
– reference: 23616660 - J Virol. 2013 Jul;87(13):7200-9
– reference: 19793828 - J Virol. 2009 Dec;83(23):12325-35
– reference: 20700447 - PLoS Pathog. 2010;6(8):e1001034
– reference: 23926340 - J Virol. 2013 Oct;87(20):11063-75
– reference: 6868370 - Virology. 1983 Jun;127(2):361-73
– reference: 16554799 - Nature. 2006 Mar 23;440(7083):435-6
– reference: 12646557 - J Biol Chem. 2003 May 30;278(22):20381-8
– reference: 18315849 - BMC Bioinformatics. 2008;9 Suppl 1:S18
– reference: 19119420 - PLoS Pathog. 2009 Jan;5(1):e1000252
– reference: 18400288 - Lancet. 2008 Apr 26;371(9622):1427-34
– reference: 10484749 - Virology. 1999 Aug 15;261(1):15-9
– reference: 19194459 - Nature. 2009 Apr 16;458(7240):914-8
– reference: 21816827 - J Biol Chem. 2011 Oct 7;286(40):34504-13
– reference: 16192482 - N Engl J Med. 2005 Sep 29;353(13):1374-85
– reference: 16840327 - J Virol. 2006 Aug;80(15):7469-80
– reference: 20016035 - J Gen Virol. 2010 May;91(Pt 5):1284-9
– reference: 22549831 - Nat Commun. 2012;3:802
SSID ssj0014464
Score 2.312139
Snippet Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60%...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 3947
SubjectTerms Adaptation, Biological
Cell Line
Epithelial Cells - virology
Genetic Diversity and Evolution
Humans
Influenza A Virus, H5N1 Subtype - genetics
Influenza A Virus, H5N1 Subtype - physiology
Influenza virus
Mutant Proteins - genetics
Mutant Proteins - metabolism
Mutation, Missense
Recombination, Genetic
Reverse Genetics
Viral Proteins - genetics
Viral Proteins - metabolism
Virus Replication
Title Identification of PB2 Mutations Responsible for the Efficient Replication of H5N1 Influenza Viruses in Human Lung Epithelial Cells
URI https://www.ncbi.nlm.nih.gov/pubmed/25609813
https://www.proquest.com/docview/1662635508
https://www.proquest.com/docview/1676352183
https://pubmed.ncbi.nlm.nih.gov/PMC4403392
Volume 89
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgCIkXNO7lJiPBU5URJ3FiPwLaNKZShGhReYocx94ydenUy6TtkV_O8SVpyjY0eImqEzdN-321_Z2cC0JvdRkVPCYyoCwVQSJoGhS81IGMQpHGOqUyNMnJX4bp_jg5mNDJ2pljs0uWxY68uDKv5H9QBRvgarJk_wHZ9qJggNeALxwBYTjeCGOXZau9282Gs32M-ierpY9vmzcBsFPVhhMqWzPCRADMVfvs2rrz6ZCY2CzTs-RC9M-q-Wpho7V8H78pTAt9dWpyOKbGzW5c_otr9rYmea7rrv8pTsRx5eD0_bobc2l3r9-Pqvq8tQ-cu1xU_W-tqXLBAao-PF7VXV8FoZ0QFze9muqlZo_mVp8rbH5Odm2FPPeyzgQbc1eg8_LMH5lshoMfn3fCOI5AGSfrFa55qj_8mu-NB4N8tDsZ3UZ3IlAWcePg8Q-eQB3bQITmpppciYi97157cxdzSZr8GWHb2bKMttF9jwf-4IjzAN1S9UN013UfPX-Efm3SB880Bvrglj64Qx8M9MGAPG7pgzv0MW819MEtfbCnD1iwpQ829MFr-mBLn8dovLc7-rQf-JYcgUxYvAxUGpWgaQllIVehpqacYBamMhOcMMF4qrOoSEqimExBaVNZxFToghNaJgksjvETtFXPavUMYSULwmWcZUxr0MBKEJAGIRFMSq7KRPdQv_mJc-nr1Zu2KdPc6taI5QBIbgEB_dpD79rRp65OyzXj3jRo5TCRmu8qajVbLXKS2sJMIFj-NsbUbzSqooeeOoTbTzPagTMCZ7IN7NsBppD75pm6OrIF3ZMEbo9Hz29wby_QvfUf6yXaWs5X6hVsi5fFa0vk34hTvX0
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+PB2+mutations+responsible+for+the+efficient+replication+of+H5N1+influenza+viruses+in+human+lung+epithelial+cells&rft.jtitle=Journal+of+virology&rft.au=Yamaji%2C+Reina&rft.au=Yamada%2C+Shinya&rft.au=Le%2C+Mai+Q&rft.au=Li%2C+Chengjun&rft.date=2015-04-01&rft.issn=1098-5514&rft.eissn=1098-5514&rft.volume=89&rft.issue=7&rft.spage=3947&rft_id=info:doi/10.1128%2FJVI.03328-14&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon